Comparison of the Treatment Outcome of Oral Tofacitinib with Other Conventional Therapies in Refractory Alopecia Totalis and Universalis: A Retrospective Study.

In conclusion, oral tofacitinib was more effective than diphenylcyclopropenone immunotherapy and more tolerable than conventional oral treatment after 6 months of treatment. PMID: 30281139 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30281139?dopt=Abstract

Source: Acta Dermato-Venereologica - October 3, 2018 Category: Dermatology Authors: Shin JW, Huh CH, Kim MW, Lee JS, Kwon O, Cho S, Park HS Tags: Acta Derm Venereol Source Type: research